SlideShare a Scribd company logo
Presented by 
Rooma Khalid 
M.Phil Pharmaceutics 
(2014-2016) 
ISLAMIA UNIVERSITY 
BAHAWALPUR
 Cosmetic regulatory bodies. 
 Basic U.S regulatory structure for cosmetics. 
 Statutory control on cosmetics. 
 Law enforcement of FD&C Act violations. 
 Regulatory control on cosmetics. 
 Cosmetic ingredients label declarations. 
 Cosmetic label warnings. 
 References.
 The FDA is the principal regulatory agency 
charged with the enforcement of the 
governing the marketing of cosmetics in the 
United states. 
 For cosmetics , the agency is given the 
mandate for enforcing the statutory 
requirements of the 1938 Federal Food Drug and 
Cosmetics Act (FD& C act, also referred to as the 
ACT), the 1960 color amendments to the Act, and 
the 1966 Federal Fair Packaging and Labeling 
Act (FPLA).
 Federal regulation of cosmetics involve oversight 
of print, radio, television and multimedia 
advertising as well as of the product package 
labeling. 
 The jurisdiction of the FTC (Federal Trade 
Commission) to regulate the advertising of 
cosmetic and “over the counter” (OTC) cosmetic-drug 
products overlaps that of FDA. 
 FDA has signed a memorandum of understanding 
(MOU) with the FTC establishing the parameters 
of relationship.
 The FDA also shares its regulatory responsibilities 
for the regulation of cosmetics and topical personal 
care products with other federal agencies. 
 The U.S Consumer Product Safety Commission 
(CPSC) also is delegated the authority under the 
1970 poison prevention packaging act (PPPA) for 
promulgating “child resistant” packaging 
regulations for cosmetic products and soap 
products.
 In recent years , final rules have been promulgated 
, requiring CR packaging for nail care products 
containing 5% methacrylic acid and household 
glue removers containing acetonitrile. 
 CR packaging would also be required for fluid 
cosmetic products formulated with 10% of low 
viscosity hydrocarbons.
 Environmental protection agency (EPA) is a fourth 
federal agency that has become a significant 
presence in the regulation of multifunctional 
personal care products, such as the OTC screen 
products/insect repellent/lotions.
BASIC U.S 
REGULATORY 
STRUCTURE FOR 
COSMETICS
 The use of the term “cosmetics” refers not only to 
finished cosmetic products marketed to consumers 
but also to constituent ingredients and other 
components of such finished products (e.g., 
packaging). 
 Under current legal standards , topical products 
functioning as cosmetics may cleanse, beautify, 
promote attractiveness, or alter the appearance 
without altering body’s structure and functions.
 Soap products are generally exempt from the 
cosmetic provisions of the FD&C Act, and, indeed 
from the definition of cosmetics given in the 
statute. 
 Liquid and solid product formulations consisting 
of synthetic detergents intended not only for 
cleansing but also for claiming other cosmetic 
product performance attributes (e.g., beauty bars) 
must comply with regulatory requirements 
applicable to cosmetics.
 The act explicitly prohibits the adulteration and 
misbranding of cosmetics. 
 The delivery of an adulterated or misbranded 
cosmetic for pay or otherwise is also a “prohibited 
act” (FD&C Act, Sec. 301).
ADULTERATED COSMETICS: 
A cosmetic is adulterated according to 
the FD&C Act, Sec.601(a)-(e) if: 
• It bears or contain any poisonous or deleterious 
substance, which may render it injurious to users 
under the conditions of use prescribed in the 
labeling or under “customary or usual” uses. 
• It consists wholly or in part of any filthy, putrid, or 
decomposed sustance.
 It has been prepared, packed, or held under 
insanitary conditions whereby it may have become 
contaminated with filth, or whereby it may have 
been rendered injurious to health. 
 Its container is composed, wholly or in part, of any 
poisonous or deleterious substance which may 
render the contents injurious to health.
 COAL TAR HAIR DYE EXEMPTION: 
The FD&C Act exempts so called 
“coal tar” hair dyes from the adulteration provision 
at section 601 (a), the coal tar hair dye exemption 
named for the synthetic organic colors originally 
derived from the coal tar derivative, aniline, to 
which the exemption was initially applied, but it 
does not include eyelash and eyebrow dyes.
 SOURCES OF ADULTERATION: 
Cosmetic adulteration may be associated 
with unintentional trace level contaminants (e.g., 
N-Nitrosamines, 1,4-Dioxane) of the ingredients 
(also referred to as the raw materials) employed in 
finished cosmetic products.
MISBRANDED COSMETICS: 
A cosmetic is “misbranded” 
according to the FD&C Act,sec. 602 (a)-(f) if: 
 Its labeling is false or misleading in a particular 
way 
 Its container is made, formed, or filled in a manner 
likely to be misleading. 
 It is a color additive, unless its packaging and 
labeling are in conformity with requirements in 
the regulations.
 Its package fails to contain the name and place of 
business of the manufacturer, packer, or 
distributor, as well as an accurate statement of the 
quantity of the contents in terms of weight, 
measure, or numerical count.
Violation of the adulteration and misbranding 
provision of the act may subject the violator to 
various enforcement tools available to the FDA; 
these include: 
 Warning letters: Which are subject to public 
disclosure under the freedom of the information 
act (FOIA), may be posted on internet FDA 
website and are regularly publicized in the trade 
press and industry news letters.
 Targeted establishment inspections and sampling 
programs. 
 “Seizure” and “detention” of cosmetic offered for 
entry into U.S interstate commerce that appear to 
be in violation of the law e.g. FD&C Act, section 
801(a) 
 “Injuction” against present and future commercial 
operations.
 “Criminal prosecution” of responsible persons 
within violator cosmetic firms 
 “Voluntary recalls.” Recalls of cosmetic products 
can either be firm-initiated or be FDA requested. 
The FDA has no authority under the FD&C to 
order the recall of a possibly harmful consumer 
product, although it can request a firm to recall a 
product.
FDA’s guidelines divide voluntary recalls into 3 
categories: 
 Category 1-products that are clearly dangerous or 
defective that pose clear or irreversible hazards to 
public health. 
 Category 2-products that are intermediate in their 
potential for adverse public health consequences, 
but may cause a temporary or reversible health 
problem.
 Category 3-products that are unlikely to cause any 
adverse health reaction but which violate FDA 
violations.
 Cosmetics marketed in United States, whether 
manufactured domestically or imported from 
abroad, must be in compliance with the provisions 
of the FD&C Act and the regulations published 
under the authority of these laws. 
 But the cosmetics are the least regulated category 
of articles subjected to the jurisdiction of the 
FD&C Act.
 There is no premarket approval requirement for 
cosmetic products or their constituent ingredients 
under the law. 
 Other than color additives and those few 
ingredients restricted or prohibited by regulation 
from use in cosmetics, no mandatory regulatory 
controls exist on the chemistry and structure of 
ingredients, conditions of manufacture of the 
finished cosmetic products, or safety testing of 
ingredients and no premarket test results need to 
be submitted to FDA.
o Promotion of “gimmick” additives, combined with 
more sophisticated cosmetic ingredients. 
 Lotion contain bovine albumin and the label 
claimed it would give a face lift without surgery. 
 Exaggerated claims of beauty or long lasting 
effects.
 Product claims should be based on skin care 
realities, promises banked on achievable 
benefits. 
 In the past, cosmetic manufacturers have 
depended upon mysterious gimmick 
additives, such as turtle oil to promote skin 
rejuvenation or tighten chin muscles, shark 
oil, queen bee royal jelly, chick embryo 
extract, horse blood serum, and pigskin 
extracts.
 Cosmetic claims, even those considered "puffery," 
are allowed without scientific substantiation. 
 But if a cosmetic makes a medical claim, such as 
removing dandruff, the product is regulated as a 
drug for which scientific studies demonstrating 
safety and efficacy must be submitted .
 Cosmetics are not currently subject to the same 
FDA safety and effectiveness standards as are 
drugs, biologics and medical devices. 
 The FD&C act does not require that cosmetic 
manufacturers or marketers test their products for 
safety, nor does the FDA specify particular test 
batteries of preclinical and human clinical safety 
tests by cosmetic product category that marketers 
must use to ensure cosmetic product safety.
 Manufacturers or marketers of cosmetic products 
are not required to submit the results of such safety 
tests to the agency on a premarket approval basis.
 The FD&C act provides no statutory authority for 
the premarket approval of cosmetic ingredients. 
 Only the color additives are subjected to pre 
market approval. 
 The marketers of finished cosmetic product bears 
legal responsibility for an adverse reactions 
experienced by consumers or public health 
consequences that may result from this action.
 The term color additive is defined in the FD&C act 
at section 201(t). 
 The 1960 color additive amendments to the FD&C 
act requires that color additives used in food, drug, 
medical devices, and cosmetics be approved by 
FDA for their intended use, a process that requires 
both chemistry and safety reviews of the color 
additive by color chemistry and toxicology staff 
experts at the FDA.
 A cosmetic containing an unlisted color additive is 
considered adulterated and subject to the 
regulatory action. 
 Color additives listed at 21 CFR 73 are 
predominantly of inorganic or botanical origins 
and are considered exempt from FDA’s “batch 
certification” requirements.
 Color additives listed at 21 CFR 74 are largely 
synthetic organic dyes and pigments and are 
subjected to FDA’s “batch certification” 
requirements. 
 The FDA regulations for cosmetic color additives 
may be listed for general use in imparting color to 
product formulations, for use in decorative 
cosmetics intended for external application to the 
hair.
 Only one color additive, dihydroxyacetone (DHA) 
is specifically listed for an intended use in 
externally applied cosmetics “to impart color to 
human body”. 
 No color additives are approved for use in inject 
able cosmetic tattoos.
 ‘Labeling’ means actual product package labels as 
well as other written, printed, or graphic material 
on or accompanying a product (e.g., hand-tags, 
package inserts). 
 Label statements required under the FD&C act 
must appear on both the inside as well as an 
outside container or wrapper 
 FPLA requirements need only appear on the label 
of outer container or wrapper.
 Cosmetic products distributed in United States 
must comply with labeling regulations published 
by the FDA under the authority of the FD&C act 
and the FPLA. 
 The FPLA gives the FDA the authority to require 
labeling of products ,that is, products regulated 
under the FD&C act.
 The statute requires that product be honestly and 
informatively labeled so that consumers can 
conduct “value comparisons” at the point of 
purchase. 
 Cosmetic product package labeling regulations 
require that cosmetic labels bear certain fields of 
information that provides the consumer with 
proper identification and understanding of the 
product being purchased.
The required fields of information includes the 
following: 
 Statement of identity, (common name) rendered in 
bold type on the cosmetic product 
 Name and address of manufacturer/distributor. 
 Cosmetic ingredient label declarations. 
 Warning statements concerning safe use.
 The FPLA specifically authorizes the FDA to 
promulgate regulations requiring the declaration of 
all the cosmetic ingredients on product package 
labels of cosmetics produced or distributed for 
retail sale to consumers for personal care. 
 Ingredient declarations must be conspicuous and 
prominent in placement on any information panel 
of the outer container.
 FPLA labeling requirements specify that cosmetic 
ingredients must be declared in qualitative 
descending order of predominance. 
 Soap is exempt from the FPLA requirement for 
mandatory label ingredient declarations applicable 
to cosmetics.
 Cosmetics containing sunscreen ingredients for 
non therapeutic, non physiological uses, must 
qualify the use of term “sunscreen”.
 Cosmetic that may be hazardous to consumers 
when misused must bear appropriate label 
warnings and adequate directions for safe use. 
 Manufacturers and marketers of cosmetics have a 
general responsibility to ensure that the labels of 
their finished cosmetic products bear a warning 
statement whenever necessary to prevent a health 
hazard that may be associated with the product.
Specific cosmetic product categories requiring such 
statements currently include: 
 Cosmetic products for which adequate 
substantiation of safety has not been obtained. 
 Cosmetics in self-pressurized containers. 
 Foaming detergent bath products. 
 “Coal tar” hair-dyes posing a risk of cancer.
TAMPER-RESISTANT PACKAGING: 
The FDA is given the authority under 
sections 601 (a) and (c) and 701(a) of the FD&C 
act to issue the package security requirements for 
cosmetics. Requirements for tamper-resistant 
packaging for liquid oral hygiene products (e.g., 
mouthwashes and breath fresheners) were 
promulgated.
 COSMETIC GOOD MANUFACTURING 
PRACTICES GUIDELINES: 
The FDA has never published current 
good manufacturing practice (cGMP) regulations 
for cosmetics, although agency has actively 
promoted good manufacturing practices by firms 
marketing cosmetics.
 THE VOLUNTARY COSMETIC REGISTRATION 
PROGRAM (VCRP): 
The FD&C act does not require 
cosmetic firms to register manufacturing 
establishments or formulations with the FDA, nor 
does it mandate that companies submit product 
adverse reaction report data. Nevertheless, the 
FDA has encouraged the voluntary registration of 
such data as being in the public interest .
 FDA does not pre-approve cosmetic products or 
ingredients, with the important exception of color 
additives 
 Cosmetic firms are responsible for marketing safe, 
properly labeled products; using no prohibited 
ingredients; and adhering to limits on restricted 
ingredients 
 Considered good practice to follow industry safety 
guidelines and recommendations.
 Must carry warning if safety is not determined but 
can still market product. 
 FDA must “go to court” to remove a cosmetic 
from the market. 
 Puffery is OK.
 http://en.wikipedia.org/wiki/History_of_cosmetics 
 http://www.cyonic-nemeton.com/Cosmetics.html 
 http://www.cosmeticsinfo.org/history.php 
 Cosmetics and Perfumes, Egypt, 10,000 BCE by Mindy Cohen, 
1999 
 A History of Fragrance ©1995 Kathi Keville and Mindy Green 
 A Hand book of cosmetics by B.M.Mithal & R.N.Sharma 
 Poucher’s perfumes, Cometics and Soaps 10th edition
REGULATORY REQUIREMENTS FOR MARKETING OF COSMETICS BY ROOMA KHALID

More Related Content

What's hot

Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
Michael Swit
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Union
Bindu Kshtriya
 
Post Marketing Survelliance.pptx
Post Marketing Survelliance.pptxPost Marketing Survelliance.pptx
Post Marketing Survelliance.pptx
PrachiSharma575050
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
Navalika Polishetty
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
JAYA PRAKASH VELUCHURI
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
Vikas Rathee
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
Parul Institute of Pharmacy
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
SusmithaTella2
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
Swapnil Fernandes
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
BhavikaAPatel
 
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALREGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
KapilKumar198
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
Arpitha Aarushi
 
NSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplementNSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplement
Atul Bhombe
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
Shoba Elangovan
 
Brazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioBrazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by Artixio
AndyThomas119
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
SyedArshiya4
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
shweta more
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANDeveshDRA
 

What's hot (20)

Combination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC DrugsCombination Products, Orphan Drugs and OTC Drugs
Combination Products, Orphan Drugs and OTC Drugs
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
labelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Unionlabelling of drugs and cosmetics in European Union
labelling of drugs and cosmetics in European Union
 
Post Marketing Survelliance.pptx
Post Marketing Survelliance.pptxPost Marketing Survelliance.pptx
Post Marketing Survelliance.pptx
 
NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)NDA/BLA/PMA and 510(k)
NDA/BLA/PMA and 510(k)
 
Regulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics inRegulatory guidelines for the development of biologics in
Regulatory guidelines for the development of biologics in
 
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIESREGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
REGULATORY REQUIREMENTS FOR ASEAN COUNTRIES
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
 
Premarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptxPremarket Notification 510(k) for Biologics [Autosaved].pptx
Premarket Notification 510(k) for Biologics [Autosaved].pptx
 
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
MARKETING AUTHORISATION, LICENSING AND QUALITY ASSESSMENT OF VACCINES IN INDI...
 
Organization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptxOrganization structure of EMA and EDQM active Substance Master File.pptx
Organization structure of EMA and EDQM active Substance Master File.pptx
 
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALREGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBAL
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 
NSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplementNSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplement
 
Plasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluationPlasma drug file and TSE/ BSE evaluation
Plasma drug file and TSE/ BSE evaluation
 
Brazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by ArtixioBrazil Cosmetics Regulations by Artixio
Brazil Cosmetics Regulations by Artixio
 
Post approval of drugs
Post approval of drugsPost approval of drugs
Post approval of drugs
 
NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...NSF International and its role in Dietary supplements & Nutraceutical industr...
NSF International and its role in Dietary supplements & Nutraceutical industr...
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
 
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPANMEDICAL DEVICE APPROVAL PROCESS IN JAPAN
MEDICAL DEVICE APPROVAL PROCESS IN JAPAN
 

Viewers also liked

MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
 MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
Baber Mehkeri
 
How to market cosmetics
How to market cosmeticsHow to market cosmetics
How to market cosmetics
Atanu Pandey
 
Kylie Cosmetics Digital Marketing Strategy
Kylie Cosmetics Digital Marketing StrategyKylie Cosmetics Digital Marketing Strategy
Kylie Cosmetics Digital Marketing Strategy
Emily Bruce
 
Rural marketing of cosmetics
Rural marketing of cosmeticsRural marketing of cosmetics
Rural marketing of cosmeticstamanna13
 
Marketing Plan MAC Cosmetics (New Product Development)
Marketing Plan MAC  Cosmetics (New Product Development)Marketing Plan MAC  Cosmetics (New Product Development)
Marketing Plan MAC Cosmetics (New Product Development)siobhan_jones
 
marketing strategy of cosmetic
marketing strategy of cosmeticmarketing strategy of cosmetic
marketing strategy of cosmetic
CHHAYA KAVITAKE
 
Digital Marketing and Social Media Marketing for Cosmetics Brands
Digital Marketing and Social Media Marketing for Cosmetics BrandsDigital Marketing and Social Media Marketing for Cosmetics Brands
Digital Marketing and Social Media Marketing for Cosmetics Brands
Happy Marketer
 
cosmetics marketing
cosmetics marketingcosmetics marketing
cosmetics marketing
Anjalee Rai
 
MAC Makeup Marketing/Brand Assessment
MAC Makeup Marketing/Brand Assessment MAC Makeup Marketing/Brand Assessment
MAC Makeup Marketing/Brand Assessment
Zoe Brook
 

Viewers also liked (9)

MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
 MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
MBA Project: PT Gloria Origita Cosmetics -US Export Strategy Draft
 
How to market cosmetics
How to market cosmeticsHow to market cosmetics
How to market cosmetics
 
Kylie Cosmetics Digital Marketing Strategy
Kylie Cosmetics Digital Marketing StrategyKylie Cosmetics Digital Marketing Strategy
Kylie Cosmetics Digital Marketing Strategy
 
Rural marketing of cosmetics
Rural marketing of cosmeticsRural marketing of cosmetics
Rural marketing of cosmetics
 
Marketing Plan MAC Cosmetics (New Product Development)
Marketing Plan MAC  Cosmetics (New Product Development)Marketing Plan MAC  Cosmetics (New Product Development)
Marketing Plan MAC Cosmetics (New Product Development)
 
marketing strategy of cosmetic
marketing strategy of cosmeticmarketing strategy of cosmetic
marketing strategy of cosmetic
 
Digital Marketing and Social Media Marketing for Cosmetics Brands
Digital Marketing and Social Media Marketing for Cosmetics BrandsDigital Marketing and Social Media Marketing for Cosmetics Brands
Digital Marketing and Social Media Marketing for Cosmetics Brands
 
cosmetics marketing
cosmetics marketingcosmetics marketing
cosmetics marketing
 
MAC Makeup Marketing/Brand Assessment
MAC Makeup Marketing/Brand Assessment MAC Makeup Marketing/Brand Assessment
MAC Makeup Marketing/Brand Assessment
 

Similar to REGULATORY REQUIREMENTS FOR MARKETING OF COSMETICS BY ROOMA KHALID

Introduction to cosmetics
Introduction to cosmeticsIntroduction to cosmetics
Introduction to cosmetics
MahmoudAbdElmoneam4
 
regulatory approval process of drug, cosmetic and neutraceutical in usa.
regulatory approval process of drug, cosmetic and neutraceutical in usa.regulatory approval process of drug, cosmetic and neutraceutical in usa.
regulatory approval process of drug, cosmetic and neutraceutical in usa.
Richa Patel
 
Cosmetics & Beauty Product Litigation
Cosmetics & Beauty Product Litigation Cosmetics & Beauty Product Litigation
Cosmetics & Beauty Product Litigation
v2zq
 
1Ecosme.pdf
1Ecosme.pdf1Ecosme.pdf
1Ecosme.pdf
S.s.k
 
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Multilanguage Serviços Regulatórios para Com Exterior
 
Cosmetics regulations in India.pptx
Cosmetics regulations in India.pptxCosmetics regulations in India.pptx
Cosmetics regulations in India.pptx
Saurabhasing Rajput
 
Cosmetic regulation
Cosmetic regulationCosmetic regulation
Cosmetic regulation
Pravin Dhas
 
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
v2zq
 
cosmeticregulation-190217191719.pptx
cosmeticregulation-190217191719.pptxcosmeticregulation-190217191719.pptx
cosmeticregulation-190217191719.pptx
SathishKumar252021
 
Definition of cosmetic products as per india by bashant
Definition of cosmetic products as per india  by bashantDefinition of cosmetic products as per india  by bashant
Definition of cosmetic products as per india by bashant
Bashant Kumar sah
 
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCOCOMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
Institute of Pharmacy, Nirma University
 
What are “Cosmeceuticals”?
What are “Cosmeceuticals”?What are “Cosmeceuticals”?
What are “Cosmeceuticals”?
EMMAIntl
 
CDSCO (regulatory affairs)
CDSCO (regulatory affairs)CDSCO (regulatory affairs)
CDSCO (regulatory affairs)
Harshjoshi108
 
Cosmetics training for colombian trade commission (october 21, 2014)
Cosmetics training for colombian trade commission (october 21, 2014)Cosmetics training for colombian trade commission (october 21, 2014)
Cosmetics training for colombian trade commission (october 21, 2014)
ProColombia
 
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETICREGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
Sourav Mohanto
 
Ensuring Compliance with U.S. FDA Cosmetics Regulations
Ensuring Compliance with U.S. FDA Cosmetics RegulationsEnsuring Compliance with U.S. FDA Cosmetics Regulations
Ensuring Compliance with U.S. FDA Cosmetics Regulations
Registrar Corp
 
COSMETIC LABELING & CLAIMS
COSMETIC LABELING & CLAIMSCOSMETIC LABELING & CLAIMS
COSMETIC LABELING & CLAIMSCraig Litts
 
Cosmetics regulations
Cosmetics  regulationsCosmetics  regulations
Cosmetics regulations
SUJITHA MARY
 
COSMETICS REGULATORY
COSMETICS REGULATORYCOSMETICS REGULATORY
COSMETICS REGULATORY
Arunpandiyan59
 

Similar to REGULATORY REQUIREMENTS FOR MARKETING OF COSMETICS BY ROOMA KHALID (20)

Introduction to cosmetics
Introduction to cosmeticsIntroduction to cosmetics
Introduction to cosmetics
 
regulatory approval process of drug, cosmetic and neutraceutical in usa.
regulatory approval process of drug, cosmetic and neutraceutical in usa.regulatory approval process of drug, cosmetic and neutraceutical in usa.
regulatory approval process of drug, cosmetic and neutraceutical in usa.
 
Cosmetics & Beauty Product Litigation
Cosmetics & Beauty Product Litigation Cosmetics & Beauty Product Litigation
Cosmetics & Beauty Product Litigation
 
1Ecosme.pdf
1Ecosme.pdf1Ecosme.pdf
1Ecosme.pdf
 
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
Adv g0010-guide-to-cosmetic-products-for-responsible-persons-v6
 
Cosmetics regulations in India.pptx
Cosmetics regulations in India.pptxCosmetics regulations in India.pptx
Cosmetics regulations in India.pptx
 
Cosmetic regulation
Cosmetic regulationCosmetic regulation
Cosmetic regulation
 
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
Brazilian Blowout - A Case Study in Failed Cosmetics Regulation
 
cosmeticregulation-190217191719.pptx
cosmeticregulation-190217191719.pptxcosmeticregulation-190217191719.pptx
cosmeticregulation-190217191719.pptx
 
Definition of cosmetic products as per india by bashant
Definition of cosmetic products as per india  by bashantDefinition of cosmetic products as per india  by bashant
Definition of cosmetic products as per india by bashant
 
Health policy
Health policyHealth policy
Health policy
 
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCOCOMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
COMPARISON OF COSMETICS REGULATION BETWEEN USFDA VS CDSCO
 
What are “Cosmeceuticals”?
What are “Cosmeceuticals”?What are “Cosmeceuticals”?
What are “Cosmeceuticals”?
 
CDSCO (regulatory affairs)
CDSCO (regulatory affairs)CDSCO (regulatory affairs)
CDSCO (regulatory affairs)
 
Cosmetics training for colombian trade commission (october 21, 2014)
Cosmetics training for colombian trade commission (october 21, 2014)Cosmetics training for colombian trade commission (october 21, 2014)
Cosmetics training for colombian trade commission (october 21, 2014)
 
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETICREGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
REGULATORY PROVISION RELATING TO MANUFACTURING OF COSMETIC
 
Ensuring Compliance with U.S. FDA Cosmetics Regulations
Ensuring Compliance with U.S. FDA Cosmetics RegulationsEnsuring Compliance with U.S. FDA Cosmetics Regulations
Ensuring Compliance with U.S. FDA Cosmetics Regulations
 
COSMETIC LABELING & CLAIMS
COSMETIC LABELING & CLAIMSCOSMETIC LABELING & CLAIMS
COSMETIC LABELING & CLAIMS
 
Cosmetics regulations
Cosmetics  regulationsCosmetics  regulations
Cosmetics regulations
 
COSMETICS REGULATORY
COSMETICS REGULATORYCOSMETICS REGULATORY
COSMETICS REGULATORY
 

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 

REGULATORY REQUIREMENTS FOR MARKETING OF COSMETICS BY ROOMA KHALID

  • 1. Presented by Rooma Khalid M.Phil Pharmaceutics (2014-2016) ISLAMIA UNIVERSITY BAHAWALPUR
  • 2.  Cosmetic regulatory bodies.  Basic U.S regulatory structure for cosmetics.  Statutory control on cosmetics.  Law enforcement of FD&C Act violations.  Regulatory control on cosmetics.  Cosmetic ingredients label declarations.  Cosmetic label warnings.  References.
  • 3.
  • 4.  The FDA is the principal regulatory agency charged with the enforcement of the governing the marketing of cosmetics in the United states.  For cosmetics , the agency is given the mandate for enforcing the statutory requirements of the 1938 Federal Food Drug and Cosmetics Act (FD& C act, also referred to as the ACT), the 1960 color amendments to the Act, and the 1966 Federal Fair Packaging and Labeling Act (FPLA).
  • 5.  Federal regulation of cosmetics involve oversight of print, radio, television and multimedia advertising as well as of the product package labeling.  The jurisdiction of the FTC (Federal Trade Commission) to regulate the advertising of cosmetic and “over the counter” (OTC) cosmetic-drug products overlaps that of FDA.  FDA has signed a memorandum of understanding (MOU) with the FTC establishing the parameters of relationship.
  • 6.  The FDA also shares its regulatory responsibilities for the regulation of cosmetics and topical personal care products with other federal agencies.  The U.S Consumer Product Safety Commission (CPSC) also is delegated the authority under the 1970 poison prevention packaging act (PPPA) for promulgating “child resistant” packaging regulations for cosmetic products and soap products.
  • 7.  In recent years , final rules have been promulgated , requiring CR packaging for nail care products containing 5% methacrylic acid and household glue removers containing acetonitrile.  CR packaging would also be required for fluid cosmetic products formulated with 10% of low viscosity hydrocarbons.
  • 8.  Environmental protection agency (EPA) is a fourth federal agency that has become a significant presence in the regulation of multifunctional personal care products, such as the OTC screen products/insect repellent/lotions.
  • 9. BASIC U.S REGULATORY STRUCTURE FOR COSMETICS
  • 10.  The use of the term “cosmetics” refers not only to finished cosmetic products marketed to consumers but also to constituent ingredients and other components of such finished products (e.g., packaging).  Under current legal standards , topical products functioning as cosmetics may cleanse, beautify, promote attractiveness, or alter the appearance without altering body’s structure and functions.
  • 11.  Soap products are generally exempt from the cosmetic provisions of the FD&C Act, and, indeed from the definition of cosmetics given in the statute.  Liquid and solid product formulations consisting of synthetic detergents intended not only for cleansing but also for claiming other cosmetic product performance attributes (e.g., beauty bars) must comply with regulatory requirements applicable to cosmetics.
  • 12.  The act explicitly prohibits the adulteration and misbranding of cosmetics.  The delivery of an adulterated or misbranded cosmetic for pay or otherwise is also a “prohibited act” (FD&C Act, Sec. 301).
  • 13. ADULTERATED COSMETICS: A cosmetic is adulterated according to the FD&C Act, Sec.601(a)-(e) if: • It bears or contain any poisonous or deleterious substance, which may render it injurious to users under the conditions of use prescribed in the labeling or under “customary or usual” uses. • It consists wholly or in part of any filthy, putrid, or decomposed sustance.
  • 14.  It has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health.  Its container is composed, wholly or in part, of any poisonous or deleterious substance which may render the contents injurious to health.
  • 15.  COAL TAR HAIR DYE EXEMPTION: The FD&C Act exempts so called “coal tar” hair dyes from the adulteration provision at section 601 (a), the coal tar hair dye exemption named for the synthetic organic colors originally derived from the coal tar derivative, aniline, to which the exemption was initially applied, but it does not include eyelash and eyebrow dyes.
  • 16.  SOURCES OF ADULTERATION: Cosmetic adulteration may be associated with unintentional trace level contaminants (e.g., N-Nitrosamines, 1,4-Dioxane) of the ingredients (also referred to as the raw materials) employed in finished cosmetic products.
  • 17. MISBRANDED COSMETICS: A cosmetic is “misbranded” according to the FD&C Act,sec. 602 (a)-(f) if:  Its labeling is false or misleading in a particular way  Its container is made, formed, or filled in a manner likely to be misleading.  It is a color additive, unless its packaging and labeling are in conformity with requirements in the regulations.
  • 18.  Its package fails to contain the name and place of business of the manufacturer, packer, or distributor, as well as an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count.
  • 19. Violation of the adulteration and misbranding provision of the act may subject the violator to various enforcement tools available to the FDA; these include:  Warning letters: Which are subject to public disclosure under the freedom of the information act (FOIA), may be posted on internet FDA website and are regularly publicized in the trade press and industry news letters.
  • 20.  Targeted establishment inspections and sampling programs.  “Seizure” and “detention” of cosmetic offered for entry into U.S interstate commerce that appear to be in violation of the law e.g. FD&C Act, section 801(a)  “Injuction” against present and future commercial operations.
  • 21.  “Criminal prosecution” of responsible persons within violator cosmetic firms  “Voluntary recalls.” Recalls of cosmetic products can either be firm-initiated or be FDA requested. The FDA has no authority under the FD&C to order the recall of a possibly harmful consumer product, although it can request a firm to recall a product.
  • 22. FDA’s guidelines divide voluntary recalls into 3 categories:  Category 1-products that are clearly dangerous or defective that pose clear or irreversible hazards to public health.  Category 2-products that are intermediate in their potential for adverse public health consequences, but may cause a temporary or reversible health problem.
  • 23.  Category 3-products that are unlikely to cause any adverse health reaction but which violate FDA violations.
  • 24.  Cosmetics marketed in United States, whether manufactured domestically or imported from abroad, must be in compliance with the provisions of the FD&C Act and the regulations published under the authority of these laws.  But the cosmetics are the least regulated category of articles subjected to the jurisdiction of the FD&C Act.
  • 25.  There is no premarket approval requirement for cosmetic products or their constituent ingredients under the law.  Other than color additives and those few ingredients restricted or prohibited by regulation from use in cosmetics, no mandatory regulatory controls exist on the chemistry and structure of ingredients, conditions of manufacture of the finished cosmetic products, or safety testing of ingredients and no premarket test results need to be submitted to FDA.
  • 26. o Promotion of “gimmick” additives, combined with more sophisticated cosmetic ingredients.  Lotion contain bovine albumin and the label claimed it would give a face lift without surgery.  Exaggerated claims of beauty or long lasting effects.
  • 27.  Product claims should be based on skin care realities, promises banked on achievable benefits.  In the past, cosmetic manufacturers have depended upon mysterious gimmick additives, such as turtle oil to promote skin rejuvenation or tighten chin muscles, shark oil, queen bee royal jelly, chick embryo extract, horse blood serum, and pigskin extracts.
  • 28.  Cosmetic claims, even those considered "puffery," are allowed without scientific substantiation.  But if a cosmetic makes a medical claim, such as removing dandruff, the product is regulated as a drug for which scientific studies demonstrating safety and efficacy must be submitted .
  • 29.  Cosmetics are not currently subject to the same FDA safety and effectiveness standards as are drugs, biologics and medical devices.  The FD&C act does not require that cosmetic manufacturers or marketers test their products for safety, nor does the FDA specify particular test batteries of preclinical and human clinical safety tests by cosmetic product category that marketers must use to ensure cosmetic product safety.
  • 30.  Manufacturers or marketers of cosmetic products are not required to submit the results of such safety tests to the agency on a premarket approval basis.
  • 31.  The FD&C act provides no statutory authority for the premarket approval of cosmetic ingredients.  Only the color additives are subjected to pre market approval.  The marketers of finished cosmetic product bears legal responsibility for an adverse reactions experienced by consumers or public health consequences that may result from this action.
  • 32.  The term color additive is defined in the FD&C act at section 201(t).  The 1960 color additive amendments to the FD&C act requires that color additives used in food, drug, medical devices, and cosmetics be approved by FDA for their intended use, a process that requires both chemistry and safety reviews of the color additive by color chemistry and toxicology staff experts at the FDA.
  • 33.  A cosmetic containing an unlisted color additive is considered adulterated and subject to the regulatory action.  Color additives listed at 21 CFR 73 are predominantly of inorganic or botanical origins and are considered exempt from FDA’s “batch certification” requirements.
  • 34.  Color additives listed at 21 CFR 74 are largely synthetic organic dyes and pigments and are subjected to FDA’s “batch certification” requirements.  The FDA regulations for cosmetic color additives may be listed for general use in imparting color to product formulations, for use in decorative cosmetics intended for external application to the hair.
  • 35.  Only one color additive, dihydroxyacetone (DHA) is specifically listed for an intended use in externally applied cosmetics “to impart color to human body”.  No color additives are approved for use in inject able cosmetic tattoos.
  • 36.  ‘Labeling’ means actual product package labels as well as other written, printed, or graphic material on or accompanying a product (e.g., hand-tags, package inserts).  Label statements required under the FD&C act must appear on both the inside as well as an outside container or wrapper  FPLA requirements need only appear on the label of outer container or wrapper.
  • 37.  Cosmetic products distributed in United States must comply with labeling regulations published by the FDA under the authority of the FD&C act and the FPLA.  The FPLA gives the FDA the authority to require labeling of products ,that is, products regulated under the FD&C act.
  • 38.  The statute requires that product be honestly and informatively labeled so that consumers can conduct “value comparisons” at the point of purchase.  Cosmetic product package labeling regulations require that cosmetic labels bear certain fields of information that provides the consumer with proper identification and understanding of the product being purchased.
  • 39. The required fields of information includes the following:  Statement of identity, (common name) rendered in bold type on the cosmetic product  Name and address of manufacturer/distributor.  Cosmetic ingredient label declarations.  Warning statements concerning safe use.
  • 40.  The FPLA specifically authorizes the FDA to promulgate regulations requiring the declaration of all the cosmetic ingredients on product package labels of cosmetics produced or distributed for retail sale to consumers for personal care.  Ingredient declarations must be conspicuous and prominent in placement on any information panel of the outer container.
  • 41.  FPLA labeling requirements specify that cosmetic ingredients must be declared in qualitative descending order of predominance.  Soap is exempt from the FPLA requirement for mandatory label ingredient declarations applicable to cosmetics.
  • 42.  Cosmetics containing sunscreen ingredients for non therapeutic, non physiological uses, must qualify the use of term “sunscreen”.
  • 43.
  • 44.  Cosmetic that may be hazardous to consumers when misused must bear appropriate label warnings and adequate directions for safe use.  Manufacturers and marketers of cosmetics have a general responsibility to ensure that the labels of their finished cosmetic products bear a warning statement whenever necessary to prevent a health hazard that may be associated with the product.
  • 45. Specific cosmetic product categories requiring such statements currently include:  Cosmetic products for which adequate substantiation of safety has not been obtained.  Cosmetics in self-pressurized containers.  Foaming detergent bath products.  “Coal tar” hair-dyes posing a risk of cancer.
  • 46. TAMPER-RESISTANT PACKAGING: The FDA is given the authority under sections 601 (a) and (c) and 701(a) of the FD&C act to issue the package security requirements for cosmetics. Requirements for tamper-resistant packaging for liquid oral hygiene products (e.g., mouthwashes and breath fresheners) were promulgated.
  • 47.  COSMETIC GOOD MANUFACTURING PRACTICES GUIDELINES: The FDA has never published current good manufacturing practice (cGMP) regulations for cosmetics, although agency has actively promoted good manufacturing practices by firms marketing cosmetics.
  • 48.  THE VOLUNTARY COSMETIC REGISTRATION PROGRAM (VCRP): The FD&C act does not require cosmetic firms to register manufacturing establishments or formulations with the FDA, nor does it mandate that companies submit product adverse reaction report data. Nevertheless, the FDA has encouraged the voluntary registration of such data as being in the public interest .
  • 49.  FDA does not pre-approve cosmetic products or ingredients, with the important exception of color additives  Cosmetic firms are responsible for marketing safe, properly labeled products; using no prohibited ingredients; and adhering to limits on restricted ingredients  Considered good practice to follow industry safety guidelines and recommendations.
  • 50.  Must carry warning if safety is not determined but can still market product.  FDA must “go to court” to remove a cosmetic from the market.  Puffery is OK.
  • 51.  http://en.wikipedia.org/wiki/History_of_cosmetics  http://www.cyonic-nemeton.com/Cosmetics.html  http://www.cosmeticsinfo.org/history.php  Cosmetics and Perfumes, Egypt, 10,000 BCE by Mindy Cohen, 1999  A History of Fragrance ©1995 Kathi Keville and Mindy Green  A Hand book of cosmetics by B.M.Mithal & R.N.Sharma  Poucher’s perfumes, Cometics and Soaps 10th edition